LOGIN  |  REGISTER
C4 Therapeutics
Compass Therapeutics

Healthcare Triangle Expands Long-Standing Customer Engagement with readabl.ai Medical Document Automation Solution

April 03, 2023 | Last Trade: US$0.74 0.04 -4.85

PLEASANTON, Calif., April 03, 2023 (GLOBE NEWSWIRE) -- Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the "Company"), a leader in digital transformation solutions including managed services, cloud enablement, and data analytics for the healthcare and life sciences industry, today announced a multi-year subscription agreement with long-standing customer CalvertHeath for readabl.ai, a medical document automation solution that streamlines patient care and reduces operating costs.

Healthcare Triangle’s readabl.ai integrates advanced document capture, image recognition, and analysis capabilities with state-of-the-art public cloud artificial intelligence/machine learning (AI/ML) and natural language processing (NLP) to recognize and extract healthcare information from documents, faxes and narrative reports. With faster data processing, readabl.ai streamlines workflow to improve patient care and clinical efficiencies while maintaining security and confidentiality, and because it uses the public cloud, readabl.ai’s AI and language processing models are continually evolving and improving. Customizable for each customer’s private cloud environment, readabl.ai is designed to meet and exceed HIPAA and HITRUST standards for information security.

“Despite the evolution of today’s healthcare technology landscape, a trail of digitized paper records still follows patients as they move through the continuum of care. Thus, healthcare providers have a growing need for efficient information management and process automation for digitizing, ingesting, classifying, and extracting heath data while ensuring data security,” said Roy Sookhoo, COO of Healthcare Triangle. “As their long-standing trusted advisor, HCTI was able to further CalvertHealth’s digital transformation by enabling them to focus on higher-value activities related to patient care rather than labor-intensive document processing. This is one of many noteworthy examples of HCTI’s customer retention and expansion strategies at work through innovative product development and marketing.”

About Healthcare Triangle

Healthcare Triangle, Inc. based in Pleasanton, California, reinforces healthcare progress through breakthrough technology and extensive industry knowledge and expertise. We support healthcare providers including hospitals and health systems, payers, and pharma/life sciences organizations in their effort to improve health outcomes. Healthcare Triangle achieves HITRUST Certification for Cloud and Data Platform (CaDP), marketed as CloudEz™ and DataEz™. HITRUST Risk-based, 2-year (r2) Certified status demonstrates to our clients the highest standards for data protection and information security. Healthcare Triangle enables the adoption of new technologies, data enlightenment, business agility, and response to immediate business needs and competitive threats. The highly regulated healthcare and life sciences industries rely on Healthcare Triangle for expertise in digital transformation encompassing the cloud, security and compliance, data lifecycle management, healthcare interoperability, and clinical and business performance optimization. For more information, visit www.healthcaretriangle.com.

Forward-Looking Statements and Safe Harbor Notice

All statements other than statements of historical facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as "projected," "expect," "possibility" and "anticipate." The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company's Prospectus filed with the SEC on October 7, 2021, previous filings, subsequent filings and future periodic reports filed with the SEC. All of the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.

The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release.

Contacts 
Investors:1-800-617-9550, This email address is being protected from spambots. You need JavaScript enabled to view it.
Media:Michael Campana, This email address is being protected from spambots. You need JavaScript enabled to view it.

Stock Quote

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB